|
Risks for serious adverse events and revision surgery were high. Elective shoulder replacement improves quality of life for patients with glenohumeral arthropathies. However, risks for postsurgical adverse events and revisions are unclear. Using a national U.K. database, researchers identified 52,000 patients (mean age, 72) who underwent 58,000 elective shoulder replacements from 1998 to 2017. Six times more shoulder replacements were performed in 2017 than in 1998. Overall, risks for serious adverse events (e.g., death, pulmonary embolism, myocardial infarction) at 30 days and 90 days after surgery were 4% and 5%, respectively. Higher risk was associated with older age and comorbidities: 30 days after surgery, risk was 2% for men who were 50 to 64 and 17% for men who were 85 and older. Ninety days after surgery, risk for serious adverse events among elders (age, ≥85) was higher for men than for women (20% vs. 11%). Lifetime risk for revision surgery was lowest for older women and highest for middle-aged men. At all ages, revision risk was highest during the first 5 years after surgery. |
|
|
|
Leave a Reply Cancel reply
You must be logged in to post a comment.
COMMENT
Risk for serious adverse events was especially high in elders (age, ≥85); at 90 days, 1 in 5 men and 1 in 9 women experienced adverse events. Middle-aged people were more likely to require revision surgery (1 in 4). Patients being considered for shoulder replacement should be selected carefully and clinicians should know about lifetime risk for revision surgery.